Bracco Imaging has obtained 510(k) clearance from the FDA and Health Canada authorisation for the VueJect contrast delivery system.The post...
Skylark Bio has dosed the first patient in its SONIX Phase I/II clinical trial assessing SKY-GJB2 as a potential gene...
Alfasigma is to buy Nordic Group, which aims to strengthen its speciality care business and expand its reach in Europe,...
AbCellera has reported encouraging top-line data from the Phase II segment of its Phase I/II study assessing ABCL635.The post AbCellera...
Acarix has secured regulatory approval for its CADScor system in the UAE, a step that paves the way for the...
Jazz Pharmaceuticals is to acquire Actio Biosciences in a deal that includes an $820m upfront payment and up to $500m...
RenovoRx has reported the first commercial clinical use of its RenovoCath device for the treatment of a sarcoma patient.The post...
Neurocrine Biosciences has initiated a Phase I clinical study to evaluate NBIP-'1968 as a potential treatment for obesity.The post Neurocrine...
Energenesis has signed a development agreement with Taiwan Tanabe for its investigational topical drug ENERGI-F703DFU to treat DFUs.The post Energenesis...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.